Some fused heterocyclic compounds as eukaryotic topoisomerase II inhibitors

Biochemical and Biophysical Research Communications

Volumn 317, Issue 2, 2004, Pages 670-674

  Pinar, Asli ^a   Yurdakul, Pinar ^a   Yildiz, Ilkay ^b   Temiz Arpaci, Ozlem ^b   Acan, N Leyla ^a   Aki Sener, Esin ^b   Yalcin, Ismail ^b  

^a HACETTEPE UNIVERSITY   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

Author keywords

Benzimidazoles; Benzothiazoles; Benzoxazoles; Inhibitory activity; Oxazolopyridines; Topoisomerase II

Indexed keywords

2 (4 ETHYLPHENYL)OXAZOLO[4,5 B]PYRIDINE; 2 PHENOXYMETHYLBENZOTHIAZOLE; 5 (4 FLUOROPHENYLCARBOXAMIDE) 2 PHENYLBENZOXAZOLE; 5 METHYL 2 (2,4 DIMETHYLPHENYL)BENZOXAZOLE; 5 METHYL 2 (4 AMINOBENZYL)BENZIMIDAZOLE; 5 METHYL 2 PHENYLTHIOMETHYLBENZIMIDAZOLE; 5 METHYLCARBOXYLATE 2 PHENYLTHIOMETHYLBENZIMIDAZOLE; 5 NITRO 2 (4 ETHOXYPHENYL)BENZOXAZOLE; 5 NITRO 2 PHENOXYMETHYLBENZIMIDAZOLE; 5 NITROBENZOXAZOLE; 6 METHYL 2 (2 NITROPHENYL)BENZOXAZOLE; 6 NITRO 2 (2 METHOXYPHENYL)BENZOXAZOLE; BENZIMIDAZOLE DERIVATIVE; BENZOTHIAZOLE DERIVATIVE; BENZOXAZOLE DERIVATIVE; DNA TOPOISOMERASE INHIBITOR; ETOPOSIDE; HETEROCYCLIC COMPOUND; OXAZOLE DERIVATIVE; OXAZOLO[4,5 B]PYRIDINE DERIVATIVE; PYRIMIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CELL FREE SYSTEM; CONCENTRATION (PARAMETERS); ENZYME ACTIVITY; EUKARYOTE; IC 50; PRIORITY JOURNAL;

ANIMALS; DNA TOPOISOMERASES, TYPE II; DROSOPHILA MELANOGASTER; ENZYME ACTIVATION; ENZYME INHIBITORS; EUKARYOTIC CELLS; HETEROCYCLIC COMPOUNDS; PLASMIDS;

EUKARYOTA;

EID: 1842426000     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.03.093     Document Type: Article

References (23)

1. Wang J.C. DNA Topoisomerases. Ann. Rev. Biochem. 54:1985;665-697.
2. Wang J.C. DNA Topoisomerases. Ann. Rev. Biochem. 65:1996;635-692.
3. Chen G.L., Yang L., Rowe T.C., Halligan B.D., Tewey K.M., Liu L.F. Nonintercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II. J. Biol. Chem. 259:1984;13560-13566.
4. Nitiss J.L. Investigating the biological function of DNA topoisomerases in eukaryotic cells. Biochem. Biophys. Acta. 1400:1998;63-81.
5. Cho K.H., Pezzuto J.M., Bolton J.L., Steele V.E., Kelloff G.J., Lee S.K., Constantinou A. Selection of cancer chemopreventive agents based on inhibition of topoisomerase II activity. Eur. J. Cancer. 36:2000;2146-2156.
6. Pindur U., Lemster T. Antitumor drug design: DNA-binding ligands, which inhibit the topoisomerase I. Pharmazie. 53:1998;79-86.
7. Alper S., Arpaci O.T., Aki E.S., Yalcin I. Some new bi- and ter-benzimidazole derivatives as topoisomerase I inhibitors. Il Farmaco. 58:2003;497-507.
8. Rowe T.C., Chen G.L., Hsiang Y.H., Liu F. DNA damage by antitumor acridines mediated by mammalian DNA topoisomerase II. Cancer Res. 46:1986;2021-2026.
9. Pommier Y., Orr A., Kohn K.W., Riou J.F. Differential effects of amsacrine and epipodophyllotoxins on topoisomerase II cleavage in the human c-myc proto-oncogene. Canser Res. 52:1992;3125-3130.
10. Finlay G.J., Baguley B.C. Potentiation by phenylbisbenzimidazoiles of cytotoxicity of anticancer drugs directed against topoisomerase II. Eur. J. Cancer. 26:1990;586-589.
11. Tolner B., Hartley J.A., Hochhauser D. Transcriptal regulation of topoisomerase IIα at confluence and pharmacological modulation of expression by bis-benzimidazole drugs. Mol. Pharmacol. 59:2001;699-706.
12. Sun Q., Gatto B., Yu C., Liu A., Liu L.F., LaVoie E.J. Synthesis and evaluation of terbenzimidazoles as topoisomerase I inhibitors. J. Med. Chem. 38:1995;3638-3644.
13. Akbay A., Oren A.I., Temiz-Arpaci O., Aki-Sener E., Yalçin I. Synthesis and HIV-1 reverse transcriptase inhibitor activity of some 2,5,6-substituted benzoxazole, benzimidazole, benzothiazole and oxazolo(4,5-b)pyridine derivatives. Arzneim. Forsch./Drug Res. 53:2003;266-271.
14. E. Aki-Sener, O. Temiz-Arpaci, I. Yalcin, N. Altanlar, Synthesis and microbiological activity of some novel 5-benzamido and 5-phenylacetamido substituted 2-phenylbenzoxazole derivatives, I1 Farmaco 55 (2002) 397-405
15. Oren I., Temiz O., Yalcin I., Sener E., Altanlar N. Synthesis and microbiological activity of some novel 2,5- and/or 6-substituted benzoxazole and benzimidazole derivatives. Eur. J. Pharm. Sci. 7:1998;153-160.
16. Temiz O., Oren I., Sener E., Yaln I., Ucarturk N. Synthesis and microbiological activity of some novel 5- or 6-methyl-2-(2,4- disubstitutedphenyl)benzoxazole derivatives. II Farmaco. 53:1998;337-341.
17. Oren I., Temiz O., Yalcin I., Sener E., Akin A., Ucarturk N. Synthesis and microbiological activity of 5(or 6)-methyl-2-substituted benzoxazolo and benzimidazole derivatives. Arzneim. Forsch./Drug Res. 47:1997;1393-1397.
18. Sener E., Yalcin I., Temiz O., Oren I., Akin A., Ucarturk N. Synthesis and structure activity relationships of some 2,5-disubstituted benzoxazoles and benzimidazoles as antimicrobial agents. II Farmaco. 52:1997;99-103.
19. Sener E., Turgut H., Yalcin I., Oren I., Turker L., Celebi N., Akin A. Structure-activity relationships of some antimicrobial 5-substituted 2-(3-pyridyl)benzoxazoles using quantum chemical calculations. Int. J. Pharm. 110:1994;109-115.
20. Yalcin I., Oren I., Sener E., Akin A., Ucarturk N. The synthesis and the structure-activity relationships of some substituted benzoxazoles, oxazolo(4,5-b)pyridines, benzothiazoles and benzimidazoles as antimicrobial agents. Eur. J. Med. Chem. 27:1992;401-406.
21. Sambrock J., Frish E.F., Maniatis T. Molecular cloning, A Laboratory Manual. second ed. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
22. Osheroff N., Shelton E.R., Brutlag D. DNA topoisomerase II from Drosophila melanogaster, relaxation of supercoiled DNA. J. Biol. Chem. 258:1983;9536-9543.
23. Barrett J.F., Sutcliffe J.A., Gootz T.D. In vitro assays used to measure the activity of topoisomerases. Antimicrob. Agents Chemother. 34:1990;1-7.